Angiogenic gene therapy with vascular endothelial growth factor — Hope or hype? | springermedizin.at

Springer Medizin Österreich

nach oben

European Surgery

Erschienen in:

01.03.2002 | Main Topics: Biotechnology In Vascular Surgery

Angiogenic gene therapy with vascular endothelial growth factor — Hope or hype?

verfasst von: J. Dulak, Ph.D., Alicja Jozkowicz

Erschienen in: European Surgery | Ausgabe 2/2002

Einloggen, um Zugang zu erhalten

Anzeige

Vorheriger Artikel Gutless adenoviral vectors — Promising tools for gene therapy

Nächster Artikel Gene transfer of naked VEGF plasmid induces the formation of microvessels but not mature collaterals in ischaemic limb muscles

Titel: Angiogenic gene therapy with vascular endothelial growth factor — Hope or hype?
verfasst von: J. Dulak, Ph.D.
Alicja Jozkowicz
Publikationsdatum: 01.03.2002
Verlag: Springer-Verlag
Erschienen in: European Surgery / Ausgabe 2/2002
Print ISSN: 1682-8631
Elektronische ISSN: 1682-4016
DOI: https://doi.org/10.1046/j.1563-2563.2002.02028.x

Weitere Artikel der Ausgabe 2/2002

Congress Announcement

Congress Announcement

Congress Announcement

Invited commentary to: ‘Virtual dissection and automated polyp detection of the colon based on spiral CT — Techniques and preliminary experience on a cadaveric phantom’ (Eur. Surg. 2002;34:143–149)

Original Scientific Papers

Ciglitazone, ligand of peroxisome proliferator-activated receptor-γ, inhibits vascular endothelial growth factor activity

Main Topics: Biotechnology In Vascular Surgery

Invited commentary to: ‘Optimizing the parameters for hydro-jet dissection in fatty tissue — A morphologicalEx Vivo analysis’ (Eur. Surg. 2002;34:137–141)

Original Scientific Papers